Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for smear-positive HIV-negative pulmonary tuberculosis
jRCT1031200344Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of prednisolone in pulmonary tuberculosis (TB), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Infectivity negative conversion. Started Jul 2021; status: completed.
02
Drugs
prednisolone
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on jRCT1031200344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031200344.